サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1684354

LDT（薬事未承認検査）の世界市場：技術別・検査の種類別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Laboratory Developed Test Market, By Technology, By Test Type, By Application, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 269 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
LDT（薬事未承認検査）の世界市場：技術別・検査の種類別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年02月04日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

LDT（薬事未承認検査）の市場規模は2024年に129億8,309万米ドルとなり、2025年から2032年にかけてCAGR 7.28%で拡大

LDT（薬事未承認検査）の市場力学

個別化医療需要の高まりが市場需要を促進

個別化医療への需要がLDT（薬事未承認検査）市場を大きく押し上げています。医療が個人の遺伝子プロファイルに合わせたものになるにつれ、精密でカスタマイズされた診断の必要性が高まっています。米国立衛生研究所（NIH）によると、遺伝子情報に基づく個別化治療が患者の転帰改善につながり、特に腫瘍学では遺伝子検査が治療方針の決定に不可欠です。2022年には、米国のがん患者の約25％が、LDTの進歩によって個別化治療を受けるようになります。さらに、個人差に基づいて治療動向を調整することを目的としたプレシジョン・メディシン・イニシアチブのようなイニシアチブがこの傾向に拍車をかけ、LDTへの依存度を高めています。希少な遺伝子変異や疾患を検出するLDTの能力は、より的を絞った治療を可能にし、医療に革命を起こす上で重要な役割を果たしています。

LDT（薬事未承認検査）市場：主な考察

弊社リサーチアナリストの分析によると、世界市場は予測期間（2025-2032年）に約7.28%のCAGRで毎年成長すると推定されます。

技術別に見ると、分子診断が2024年に最大市場シェアを示すと予測されました。

検査の種類別では、マルチ遺伝子パネルが2024年の主要な検査の種類です。

用途別では、感染症検査が2024年の主要用途でした。

地域別では、北米が2024年の主要収益源であった

LDT（薬事未承認検査）市場：セグメンテーション分析

世界のLDT（薬事未承認検査）市場は、技術、検査の種類、用途、エンドユーザー、地域別に区分されます。

市場は技術に基づいて4つのカテゴリーに分けられます：分子診断、免疫測定、臨床化学、次世代シーケンシング（NGS）です。分子診断学は、その精度と遺伝子検査への応用により、最も高い優先順位を占めています。次世代シーケンシング（NGS）がこれに続き、免疫測定法と臨床化学はより広範な診断目的のための重要なツールとして機能しています。

市場は検査の種類によって4つのカテゴリーに分けられます：単一遺伝子検査、マルチ遺伝子パネル、全エクソームシーケンシング、全ゲノムシーケンシングです。マルチ遺伝子パネルは、疾患検出への包括的アプローチによりリードしています。全ゲノムシーケンシング（WGS）がこれに続き、詳細な分析を提供します。単一遺伝子検査と全エクソームシークエンシング（WES）は極めて重要だが、より専門的な用途があります。

LDT（薬事未承認検査）市場：地域別分析

LDT（薬事未承認検査）市場はさまざまな地域で著しい成長を示しており、北米は高度な医療インフラと個別化医療への高い需要によりリードしています。特に米国は、精密医療と遺伝子検査の導入が原動力となり、LDT市場が堅調に推移しています。米国食品医薬品局（FDA）によると、LDTは腫瘍学と希少疾患において極めて重要であり、この分野は急速に拡大しています。欧州もこれに追随しており、ドイツや英国などの国々は、特にがん診断において、患者の転帰を改善するための臨床検査の技術革新に注力しています。欧州医薬品庁（EMA）は、LDT開発を強化するための規制枠組みを支援しています。アジア太平洋地域では、日本、中国、インドなどが、慢性疾患の増加、医療投資の増加、遺伝子検査へのアクセス拡大などを背景に、LDTの急速な普及を見せています。特に中国は、政府が医療改革を推進しているため、ゲノム検査市場においてLDTが増加しています。

LDT（薬事未承認検査）市場：競合情勢

LDT（薬事未承認検査）市場は競争が激しく、主要企業は製品のイノベーション、規制への対応、地理的範囲の拡大に注力しています。同市場では、サーモフィッシャーサイエンティフィック、ロシュ・ダイアグノスティックス、アボット・ラボラトリーズ、ラボコープなどの企業が、幅広い診断ソリューションを提供しています。例えば、サーモフィッシャーサイエンティフィックは、遺伝子検査や分子検査を容易にし、個別化医療を可能にする技術でLDT製品を進化させています。同様に、ロシュ・ダイアグノスティックスは、規制基準と臨床的要求の両方に適合する診断プラットフォームの開発により、大きな進歩を遂げました。さらに、LabCorpとQuest Diagnosticsは、臨床試験検査サービスを提供し、特に腫瘍学と遺伝子診断において、検査室が開発した検査へのアクセスを拡大することで、牽引役となっています。FDAやEMAといった競合情勢を形成する規制機関は、企業が遵守すべきガイドラインを制定することで、患者の安全性を確保しつつイノベーションを促進するという重要な役割を果たしています。バイオテクノロジー企業と医療提供者との協力関係の高まりは、市場の競争をさらに激化させています。

目次

第1章 LDT（薬事未承認検査）市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 LDT（薬事未承認検査）の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 LDT（薬事未承認検査）市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 LDT（薬事未承認検査）市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 LDT（薬事未承認検査）の市場情勢

  • LDT（薬事未承認検査）の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 LDT（薬事未承認検査）市場：技術別

  • 概要
    • セグメント別シェア分析：技術別
    • 分子診断
    • 免疫測定
    • 臨床化学
    • 次世代シーケンシング（NGS）

第8章 LDT（薬事未承認検査）市場：検査の種類別

  • 概要
    • セグメント別シェア分析：検査の種類別
    • 単一遺伝子検査
    • マルチ遺伝子パネル
    • 全エクソームシーケンシング（WES）
    • 全ゲノムシーケンシング（WGS）

第9章 LDT（薬事未承認検査）市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 腫瘍学検査
    • 遺伝子検査
    • 感染症検査
    • 神経疾患検査

第10章 LDT（薬事未承認検査）市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 病院・クリニック
    • 診断検査室
    • 研究機関

第11章 LDT（薬事未承認検査）市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ（MEA）
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：LDT（薬事未承認検査）業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Thermo Fisher Scientific Inc.
    • NeoGenomics Laboratories, Inc.
    • PerkinElmer, Inc.
    • Bio-Rad Laboratories, Inc.
    • Fulgent Genetics, Inc.
    • Invitae Corporation
    • ARUP Laboratories, Inc.
    • Mayo Clinic Laboratories
    • Exact Sciences Corporation
    • Genomic Health, Inc.
    • Guardant Health, Inc.
    • Natera, Inc.
    • QIAGEN NV
    • Illumina, Inc.
    • Others

第13章 AnalystViewの全方位的分析

目次
Product Code: ANV4770

REPORT HIGHLIGHT

Laboratory Developed Test Market size was valued at US$ 12,983.09 Million in 2024, expanding at a CAGR of 7.28% from 2025 to 2032.

The Laboratory Developed Test (LDT) market involves medical tests created and used within individual laboratories rather than approved by regulatory bodies like the FDA. With a rise in personalized medicine, the demand for LDTs has surged, offering more tailored healthcare solutions. In 2023, approximately 60% of diagnostic tests performed in U.S. hospitals were LDTs, underscoring their growing popularity. However, regulatory challenges persist as some LDTs are not subject to the same scrutiny as FDA-approved tests. Additionally, the market faces restraints due to rising concerns over the quality and accuracy of these tests. Opportunities lie in advancements in molecular diagnostics, increased research on disease-specific markers, and expanding healthcare access in emerging economies. Furthermore, collaborations between diagnostic labs and healthcare providers are anticipated to enhance the development of innovative LDTs for complex conditions like cancer and genetic disorders.

Laboratory Developed Test Market- Market Dynamics

Rising demand for personalized medicine growth to propel market demand

The demand for personalized medicine has significantly boosted the laboratory-developed test (LDT) market. As healthcare becomes more tailored to individual genetic profiles, the need for precise and customized diagnostics grows. According to the National Institutes of Health (NIH), personalized treatments based on genetic information are leading to improved patient outcomes, particularly in oncology, where genetic tests are essential for determining treatment plans. In 2022, around 25% of cancer patients in the U.S. underwent personalized treatment, driven by advancements in LDTs. Additionally, initiatives such as the Precision Medicine Initiative, which aims to tailor medical treatments based on individual differences, further fuel this trend, increasing the reliance on LDTs. The ability of LDTs to detect rare genetic mutations or diseases allows for better-targeted therapies and plays a vital role in revolutionizing healthcare.

Laboratory Developed Test Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.28% over the forecast period (2025-2032)

Based on Technology segmentation, Molecular Diagnostics was predicted to show maximum market share in the year 2024

Based on Test Type segmentation, Multi-Gene Panels were the leading Test Type in 2024

Based on Application segmentation, Infectious Disease Testing was the leading Application in 2024

On the basis of region, North America was the leading revenue generator in 2024

Laboratory Developed Test Market- Segmentation Analysis:

The Global Laboratory Developed Test Market is segmented on the basis of Technology, Test Type, Application, End-User, and Region.

The market is divided into four categories based on Technology: Molecular Diagnostics, Immunoassays, Clinical Chemistry, and Next-Generation Sequencing (NGS). Molecular diagnostics holds the highest priority due to its precision and applications in genetic testing. Next-generation sequencing (NGS) follows closely, while immunoassays and clinical chemistry serve as critical tools for broader diagnostic purposes.

The market is divided into four categories based on Test Type: Single-Gene Tests, Multi-Gene Panels, Whole Exome Sequencing, and Whole Genome Sequencing. Multi-gene panels lead due to their comprehensive approach to disease detection. Whole genome sequencing (WGS) follows, offering in-depth analysis. Single-gene tests and whole exome sequencing (WES) are crucial but have more specialized applications.

Laboratory Developed Test Market- Geographical Insights

The Laboratory Developed Test (LDT) market shows significant growth across various regions, with North America leading due to advanced healthcare infrastructure and a high demand for personalized medicine. The U.S. particularly stands out with a robust market for LDTs, driven by the adoption of precision medicine and genetic testing. According to the U.S. Food and Drug Administration (FDA), LDTs are crucial in oncology and rare diseases, sectors that are expanding rapidly. Europe follows closely, with countries like Germany and the UK focusing on innovation in laboratory testing to improve patient outcomes, especially in cancer diagnostics. The European Medicines Agency (EMA) supports regulatory frameworks to enhance LDT development. In Asia-Pacific, countries such as Japan, China, and India are showing rapid adoption of LDTs, driven by a rise in chronic diseases, increasing healthcare investments, and expanding access to genetic testing. China, in particular, is seeing a rise in LDTs in the genomic testing market, as the government promotes healthcare reforms.

Laboratory Developed Test Market- Competitive Landscape:

The Laboratory Developed Test (LDT) market is highly competitive, with key players focusing on product innovation, regulatory compliance, and expanding their geographical reach. Prominent companies in the market include Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, and LabCorp, which offer a wide range of diagnostic solutions. Thermo Fisher Scientific, for instance, has advanced its LDT offerings with technologies that facilitate genetic and molecular testing, enabling personalized medicine. Similarly, Roche Diagnostics has made significant strides by developing diagnostic platforms that comply with both regulatory standards and clinical demands. Additionally, LabCorp and Quest Diagnostics are gaining traction by providing clinical trial testing services and broadening access to laboratory-developed tests, especially in oncology and genetic diagnostics. Regulatory bodies such as the FDA and EMA play a crucial role in shaping the competitive landscape by establishing guidelines that companies must adhere to, fostering innovation while ensuring patient safety. The increasing collaboration between biotech firms and healthcare providers further intensifies competition in the market.

Recent Developments:

In April 2024, The FDA is taking action to ensure the safety and effectiveness of Laboratory Developed Tests (LDTs). A final rule clarifies that LDTs are subject to FDA oversight, with a four-year phaseout of enforcement discretion. This aims to provide reliable test results for important healthcare decisions.

In August 2023, The FDA launched a pilot program for oncologic drugs used with in vitro diagnostic tests due to concerns about unapproved Laboratory Developed Tests (LDTs). The FDA will request performance data from drug manufacturers and provide minimum performance standards for non-FDA-approved tests to ensure patient safety and treatment effectiveness.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LABORATORY DEVELOPED TEST MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific Inc.
  • NeoGenomics Laboratories, Inc.
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Fulgent Genetics, Inc.
  • Invitae Corporation
  • ARUP Laboratories, Inc.
  • Mayo Clinic Laboratories
  • Exact Sciences Corporation
  • Genomic Health, Inc.
  • Guardant Health, Inc.
  • Natera, Inc.
  • QIAGEN N.V.
  • Illumina, Inc.
  • Others

GLOBAL LABORATORY DEVELOPED TEST MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Molecular Diagnostics
  • Immunoassays
  • Clinical Chemistry
  • Next-Generation Sequencing (NGS)

GLOBAL LABORATORY DEVELOPED TEST MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Single-Gene Tests
  • Multi-Gene Panels
  • Whole Exome Sequencing (WES)
  • Whole Genome Sequencing (WGS)

GLOBAL LABORATORY DEVELOPED TEST MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology Testing
  • Genetic Testing
  • Infectious Disease Testing
  • Neurological Disorder Testing

GLOBAL LABORATORY DEVELOPED TEST MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research Institutions

GLOBAL LABORATORY DEVELOPED TEST MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Laboratory Developed Test Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Laboratory Developed Test Market Snippet by Technology
    • 2.1.2. Laboratory Developed Test Market Snippet by Test Type
    • 2.1.3. Laboratory Developed Test Market Snippet by Application
    • 2.1.4. Laboratory Developed Test Market Snippet by End-User
    • 2.1.5. Laboratory Developed Test Market Snippet by Country
    • 2.1.6. Laboratory Developed Test Market Snippet by Region
  • 2.2. Competitive Insights

3. Laboratory Developed Test Key Market Trends

  • 3.1. Laboratory Developed Test Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Laboratory Developed Test Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Laboratory Developed Test Market Opportunities
  • 3.4. Laboratory Developed Test Market Future Trends

4. Laboratory Developed Test Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Laboratory Developed Test Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Laboratory Developed Test Market Landscape

  • 6.1. Laboratory Developed Test Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Laboratory Developed Test Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 7.1.2. Molecular Diagnostics
    • 7.1.3. Immunoassays
    • 7.1.4. Clinical Chemistry
    • 7.1.5. Next-Generation Sequencing (NGS)

8. Laboratory Developed Test Market - By Test Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 8.1.2. Single-Gene Tests
    • 8.1.3. Multi-Gene Panels
    • 8.1.4. Whole Exome Sequencing (WES)
    • 8.1.5. Whole Genome Sequencing (WGS)

9. Laboratory Developed Test Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Oncology Testing
    • 9.1.3. Genetic Testing
    • 9.1.4. Infectious Disease Testing
    • 9.1.5. Neurological Disorder Testing

10. Laboratory Developed Test Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 10.1.2. Hospitals & Clinics
    • 10.1.3. Diagnostic Laboratories
    • 10.1.4. Research Institutions

11. Laboratory Developed Test Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Laboratory Developed Test Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Laboratory Developed Test Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Laboratory Developed Test Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Laboratory Developed Test Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Laboratory Developed Test Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Laboratory Developed Test Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Laboratory Corporation of America Holdings
    • 12.2.2. Quest Diagnostics Incorporated
    • 12.2.3. Thermo Fisher Scientific Inc.
    • 12.2.4. NeoGenomics Laboratories, Inc.
    • 12.2.5. PerkinElmer, Inc.
    • 12.2.6. Bio-Rad Laboratories, Inc.
    • 12.2.7. Fulgent Genetics, Inc.
    • 12.2.8. Invitae Corporation
    • 12.2.9. ARUP Laboratories, Inc.
    • 12.2.10. Mayo Clinic Laboratories
    • 12.2.11. Exact Sciences Corporation
    • 12.2.12. Genomic Health, Inc.
    • 12.2.13. Guardant Health, Inc.
    • 12.2.14. Natera, Inc.
    • 12.2.15. QIAGEN N.V.
    • 12.2.16. Illumina, Inc.
    • 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us